Luigi Formisano

Luigi Formisano

Università degli Studi di Napoli Federico II - Napoli / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1797480
University of Naples Federico II
person_outline Luigi Formisano's MOST POPULAR ARTICLES
1-) A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2− Metastatic Breast Cancer Clinical cancer research 23 (1), 26-34, 2017
2-) Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer Nature communications 10 (1), 1373, 2019
3-) Kinome-wide RNA interference screen reveals a role for PDK1 in acquired resistance to CDK4/6 inhibition in ER-positive breast cancer Cancer research 77 (9), 2488-2499, 2017
4-) CDK 4/6 inhibitors as single agent in advanced solid tumors Frontiers in oncology 8, 608, 2018
5-) Mechanisms of lapatinib resistance in HER2-driven breast cancer Cancer treatment reviews 41 (10), 877-883, 2015